Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro.
about
Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccinesA malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparumOpsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome.Heritability of antibody isotype and subclass responses to Plasmodium falciparum antigensA distinct peripheral blood monocyte phenotype is associated with parasite inhibitory activity in acute uncomplicated Plasmodium falciparum malaria.Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe childrenThe quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malariaIL4 gene polymorphism and previous malaria experiences manipulate anti-Plasmodium falciparum antibody isotype profiles in complicated and uncomplicated malaria.HIV-1 vaccines: challenges and new perspectivesClinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study.Schistosomiasis coinfection in children influences acquired immune response against Plasmodium falciparum malaria antigensDevelopment of fluorescent Plasmodium falciparum for in vitro growth inhibition assaysVaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes.Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccinesA malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune responseEvaluation of naturally acquired IgG antibodies to a chimeric and non-chimeric recombinant species of Plasmodium vivax reticulocyte binding protein-1: lack of association with HLA-DRB1*/DQB1* in malaria exposed individuals from the Brazilian Amazon.Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposurePredicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria.Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.Genetic polymorphism and amino acid sequence variation in Plasmodium falciparum GLURP R2 repeat region in Assam, India, at an interval of five yearsEffect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigensImmunity to asexual blood stage malaria and vaccine approaches.Plasmodium falciparum merozoite surface protein 2: epitope mapping and fine specificity of human antibody response against non-polymorphic domains.In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9Plasmodium falciparum line-dependent association of in vitro growth-inhibitory activity and risk of malaria.New prospects for a preventive HIV-1 vaccine.Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2.Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria.Assessment of antibody-dependent respiratory burst activity from mouse neutrophils on Plasmodium yoelii malaria challenge outcome.Protective immunity against malaria after vaccination.Comparative haematological parameters of HbAA and HbAS genotype children infected with Plasmodium falciparum malaria in Yemen.Differential regulation of IgG subclasses and IgE antimalarial antibody responses in complicated and uncomplicated Plasmodium falciparum malaria.Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro.Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria.Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodiesStrain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodiesFlow cytometric readout based on Mitotracker Red CMXRos staining of live asexual blood stage malarial parasites reliably assesses antibody dependent cellular inhibition.FcγRIIa polymorphism and anti-malaria-specific IgG and IgG subclass responses in populations differing in susceptibility to malaria in Burkina Faso.
P2860
Q21032495-82B3C328-C769-429D-884E-BA7239C2EAAAQ24814432-E73EFDFA-247F-40D8-9474-B2E9EDF812C8Q31169310-A4525B84-6237-436F-8112-34A1477DD717Q33345340-B079D65A-ED62-4725-85E1-03950CB8FA03Q33509282-8477E9D5-D66E-45DD-8B10-D1731EC6EE87Q33511953-33659FF9-B64B-45DC-8730-E4FDED333EEEQ33512533-82E24875-9B42-433F-AF58-782FFEE203A0Q33512926-9E80C255-16D7-45D5-8DE1-623D0F235661Q33562843-9D8C79E1-F20E-496B-BBE8-A451B9386612Q33577972-C3685F64-509A-4108-9A69-F2DC0B40DCBBQ33664238-B35987B0-674C-4A30-974A-0B33787418E7Q33697651-ABE8ACF9-084B-4DEB-AD88-5AFA3B91D194Q33939788-BCC260E8-01DA-4FCF-A302-975A15A0AEE2Q33977866-870C68BE-87A1-4358-BFB3-626CD8C9210DQ33980021-0B797AE7-A96B-4F2B-BBF2-AB2100B3FE65Q34057711-93EA0F15-7394-4CB2-8F38-060CB4AA85A8Q34071439-C02CCC59-8578-485E-A67A-ACD04A719785Q34078790-AE2FC8E5-EE2F-45D2-B668-D29D342CFCA7Q34257253-A7F73F45-F89C-431E-B634-CF498EB3129BQ34303373-539F5B95-3F1B-4817-8F2F-40715E7C2793Q34515219-A7979DF3-9C76-40B8-8359-982ADE6DDEB2Q34636542-2A29D060-1A3F-4C80-A119-839EDAE99C68Q34778078-280BD206-6240-47E4-9E1F-C3B5D84CEA5DQ34842236-14C1E0C4-D96D-45F2-BE91-D6BCD41CB04AQ35060442-5F83B699-5765-45CA-B3DD-1CA50F5275C7Q35898819-ADC44366-24A8-4F0C-A567-A22EB6F3BAFEQ35944117-CB6D803E-9239-479D-8CAF-056406EF0A06Q36223864-BA5BEED9-6A8C-4781-A0DC-339D4A0BC9FDQ36396844-0F60145E-1735-400E-B303-BEC03B4B3A04Q36550447-FD087781-7701-40C3-B668-297267D05580Q37496763-C40A9837-CB93-4EBA-BD09-43119D8EC906Q38159714-60DE68F6-1BA6-4CFF-A45C-70DE940CB42CQ39198051-F90DF8CD-92CB-429C-9470-FBEFE5D5C644Q39510141-ED68C1A2-1426-44AA-A78D-8FC391C56433Q39515245-AF0C2262-E804-473C-B48A-A959E7DA2E7BQ40064367-DAC30086-93E6-4911-A9C8-20388391C9D4Q41172326-85144700-4596-4F2C-85F8-33B8B84638DCQ42102268-059D9855-BE3A-4F09-8442-DCDF6E448919Q42275109-3CC15668-BF13-4C75-AB20-2921291E5E95Q43929748-769B11B1-21D0-4DEC-BC21-2A45AF1D0FBA
P2860
Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Plasmodium falciparum: a major ...... n of parasite growth in vitro.
@en
Plasmodium falciparum: a major ...... n of parasite growth in vitro.
@nl
type
label
Plasmodium falciparum: a major ...... n of parasite growth in vitro.
@en
Plasmodium falciparum: a major ...... n of parasite growth in vitro.
@nl
prefLabel
Plasmodium falciparum: a major ...... n of parasite growth in vitro.
@en
Plasmodium falciparum: a major ...... n of parasite growth in vitro.
@nl
P356
P1476
Plasmodium falciparum: a major ...... n of parasite growth in vitro.
@en
P356
10.1006/EXPR.2001.4619
P577
2001-05-01T00:00:00Z